Lara Longpre Biography and Net Worth

Lara Longpre joined Mirum in 2018 as chief development officer with responsibility for program leadership, regulatory affairs, biometrics, and medical writing.  She brings more than 30 years of experience in the biopharmaceutical industry developing innovative and complex therapies.

Prior to Mirum, she served as chief operating officer at MedGenesis Therapeutix and Jennerex Biotherapeutics where she held responsibilities for program management, alliance management, clinical operations, technical operations, regulatory affairs, and quality assurance. She previously held several leadership roles in Contract Research Organizations including PRA International and CroMedica International where had responsibility for clinical operations and project management, global regulatory affairs, and proposals & contracts.

Lara received a Master of Medical Science degree from Harvard Medical School, an M.B.A. from Queen’s University in Ontario, Canada, and her undergraduate degree in biology from Cornell University.

What is Lara Longpre's net worth?

The estimated net worth of Lara Longpre is at least $4.87 million as of January 8th, 2024. Ms. Longpre owns 105,254 shares of Mirum Pharmaceuticals stock worth more than $4,871,155 as of March 27th. This net worth estimate does not reflect any other assets that Ms. Longpre may own. Additionally, Ms. Longpre receives a salary of $678,200.00 as Chief Development Officer at Mirum Pharmaceuticals. Learn More about Lara Longpre's net worth.

How old is Lara Longpre?

Ms. Longpre is currently 54 years old. There are 5 older executives and no younger executives at Mirum Pharmaceuticals. The oldest executive at Mirum Pharmaceuticals is Mr. Eric H. Bjerkholt M.B.A., Chief Financial Officer, who is 64 years old. Learn More on Lara Longpre's age.

What is Lara Longpre's salary?

As the Chief Development Officer of Mirum Pharmaceuticals, Inc., Ms. Longpre earns $678,200.00 per year. There are 2 executives that earn more than Ms. Longpre. The highest earning executive at Mirum Pharmaceuticals is Mr. Christopher Peetz, Co-Founder, CEO and Director, who commands a salary of $1,310,000.00 per year. Learn More on Lara Longpre's salary.

How do I contact Lara Longpre?

The corporate mailing address for Ms. Longpre and other Mirum Pharmaceuticals executives is 950 TOWER LANE SUITE 1050, FOSTER CITY CA, 94404. Mirum Pharmaceuticals can also be reached via phone at (650) 667-4085 and via email at ir@mirumpharma.com. Learn More on Lara Longpre's contact information.

Has Lara Longpre been buying or selling shares of Mirum Pharmaceuticals?

Lara Longpre has not been actively trading shares of Mirum Pharmaceuticals during the past quarter. Most recently, Lara Longpre sold 1,019 shares of the business's stock in a transaction on Monday, January 8th. The shares were sold at an average price of $28.04, for a transaction totalling $28,572.76. Following the completion of the sale, the insider now directly owns 105,254 shares of the company's stock, valued at $2,951,322.16. Learn More on Lara Longpre's trading history.

Who are Mirum Pharmaceuticals' active insiders?

Mirum Pharmaceuticals' insider roster includes Eric Bjerkholt (CFO), Ian Clements (CFO), James Flynn (Major Shareholder), Michael Grey (Chairman of the Board), Patrick Heron (Director), Jolanda Howe (SVP), Lara Longpre (Chief Development Officer), Christopher Peetz (Co-Founder, CEO and Director), Joanne Quan (Chief Medical Officer), Peter Radovich (President & Chief Operating Officer), Saira Ramasastry (Director), and Pamela Vig (Insider). Learn More on Mirum Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Mirum Pharmaceuticals?

During the last twelve months, Mirum Pharmaceuticals insiders bought shares 4 times. They purchased a total of 3,680 shares worth more than $124,300.35. During the last twelve months, insiders at the sold shares 17 times. They sold a total of 172,113 shares worth more than $7,304,987.14. The most recent insider tranaction occured on March, 17th when SVP Jolanda Howe sold 57,606 shares worth more than $2,554,826.10. Insiders at Mirum Pharmaceuticals own 22.9% of the company. Learn More about insider trades at Mirum Pharmaceuticals.

Information on this page was last updated on 3/17/2025.